Sphera Funds Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Sphera Funds Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,476,000	Closed	-$311K	–	104
2023 Q2	$311K	Hold	1,476,000	–	–	0.05%	85
2023 Q1	$236K	Hold	1,476,000	–	–	0.04%	73
2022 Q4	$819K	Hold	1,476,000	–	–	0.18%	52
2022 Q3	$1.76M	Buy	+1,476,000	New	+$1.59M	0.24%	57
2014 Q1	–	Sell	-100,000	Closed	-$1.38M	–	139
2013 Q4	$1.38M	Buy	+100,000	New	+$1.41M	0.38%	61

Other funds holding INFI

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Sphera Funds Management's INFI Position: Q3 2023 in Review

Sphera Funds Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 1,476,000 shares — an estimated $311K sold.

Sphera Funds Management first reported a position in INFI in Q4 2013 and held it in 5 quarters. The position peaked at $1.76M in Q3 2022. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

Sphera Funds Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Sphera Funds Management sold 1,476,000 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $311K.
Sphera Funds Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2013 and held it in 5 quarters.
Sphera Funds Management's Infinity Pharmaceuticals, Inc. position peaked at $1.76M in Q3 2022.
3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Sphera Funds Management's 13F filing for Q3 2023, filed 14 Nov 2023.